Skip to main content
SpringerLink
Log in

Immunologische Aspekte in Diagnose und Therapie von Neoplasien

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 88))

  • 35 Accesses

Zusammenfassung

Die Immunologie ist, wenn ich das so sagen darf, nach der Chirurgie, der Strahlen- und der Chemotherapie das jüngste Kind der Onkologie — einerseits in vielen bisherigen Ergebnissen durchaus noch problematisch, andererseits mit Entwicklungspotenzen ausgestattet, die über die der älteren Geschwister weit hinausreichen. Ziel der Referate dieses Nachmittags — vier diagnostischer, drei therapeutischer — ist es daher, einen kritischen Querschnitt über den aktuellen Stand aus berufenem Munde zu geben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aisenberg AC, Wilkes BM (1981) Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia. Cancer Res 41: 4810–4813

    PubMed  CAS  Google Scholar 

  • Goldenberg DM, DeLand F, Kin E, Bennett S, Primus FJ, Van Nagell JR, Estes N, DeSimone P, Rayburn P (1978) Use of radiolabelled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384–1388

    Article  PubMed  CAS  Google Scholar 

  • Greaves M, Delia D, Sutherland R, Rao J, Verbi W, Kemshead J, Hariri G, Goldstein G, Kung P (1981) Expression of OKT monoclonal antibody defined antigenic determinants in malignancy. Int J Immunopharmacol 3: 283–299

    Article  PubMed  CAS  Google Scholar 

  • von Kleist S, Fiebig H-H (1981) Release of CEA from human colonic carcinomas grafted into nude mice: Are there non secretor tumors? Oncodev Biol Med 1: P26

    Google Scholar 

  • von Kleist S, Wittekind C, Sandritter W, Gropp H (1981) CEA positivity in sera and breast tumor tissue obtained from the same patients. Pathol Res Pract (in press)

    Google Scholar 

  • Lindgren J, Wahlström T, Seppälä M (1979) Tissue CEA in premalignant epithelial lesions and epidermoid carcinoma of the uterine cervix: Prognostic significance. Int J Cancer 23: 448–453

    Google Scholar 

  • Mach JP, Carrel S, Forni M, Ritchard J, Donath A, Alberto P (1980) Tumor localization of radiolabelled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 303: 5–10

    Article  PubMed  CAS  Google Scholar 

  • Pagé M, Belles-Isles M (1980) Daunomycin targetting by antibodies to oncofoetal proteins. In: Embryonic antigens in cancer ( Meeting abstr.) Tallinn, USSR

    Google Scholar 

  • Ritz J, Pesando JM, Notis-McConarty J, Clavell LA, Sallan SE, Schlossman SF (1981) Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res 41: 4771–4775

    PubMed  CAS  Google Scholar 

  • Talerman A, Haije WG, Baggerman L (1978) Serum alphafetoprotein ( AFP) in diagnosis and management of endodermal sinus (yolk sack) tumor and mixed germ cell tumor of the ovary. Cancer 41: 272–278

    Google Scholar 

  • Wiels J, Fellons M, Tursz T (1981) Monoclonal antibodies against a Burkitt Lymphoma-associated antigen. Proc Natl Acad Sci USA 78: 6485–6488

    Article  PubMed  CAS  Google Scholar 

  • Wittekind C, von Kleist S, Sandritter W (1981) CEA positivity in tissue and sera of patients with benign breast lesions. Oncodev Biol Med 2: 381–390

    PubMed  CAS  Google Scholar 

  • Literatur

    Google Scholar 

  • Belpomme D et al. (1977) Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemias Lancet 1: 555

    Google Scholar 

  • Borella L, Sen L (1973) T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J Immunol 111: 1257

    Google Scholar 

  • Bross KJ et al. (1978) Demonstration of cell surface antigens and their antibodies by the peroxidase-anti-per¬oxidase method. Transplantation 25: 331

    Google Scholar 

  • Brouet JC, et al. (1976) Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients. Br J Haematol 33: 319

    Article  PubMed  CAS  Google Scholar 

  • Brouet JC et al. (1979) Acute lymphoblastic leukemia with Pre-B-cell characteristics. Blood 54: 269 — Greaves MF et al. (1977) Membrane phenotyping: diagnosis monitoring and classification of acute “lymphoid” leukemias. In: Thierfelder S, Rodt H, Thiel E (eds) Hematology and blood transfusion, vol II. Springer, Berlin Heidelberg New York, p 61

    Google Scholar 

  • Greaves MF et al. (1975) Antisera to acute lymphatic leukemia cells. Clin Immunol Immunopathol 4: 67

    Article  PubMed  CAS  Google Scholar 

  • Greaves MF (1981) Monoclonal antibodies as probes for leukemic heterogeneity and hemopoietic differentiation. In: Knapp W (ed) Leukemia markers. Academic Press, London New York Toronto Sydney San Francisco, p 19

    Google Scholar 

  • Liszka K et al. (1981) A monoclonal antibody (VIL-AL) reactive with common acute lymphatic leukemia (CALL) cells. In: Knapp W (ed) Leukemia markers. Academic Press, London New York Toronto Sydney San Francisco, p 61

    Google Scholar 

  • Minowada Jet al. (1978) Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst 60: 1269

    Google Scholar 

  • Reinherz EL et al. (1979) Ia determinants on human T-cell subsets defined by monoclonal antibody. J Exp Med 150: 1472

    Article  PubMed  CAS  Google Scholar 

  • Reinherz EL et al. (1980) Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblastis of T-cell lineage. Proc Natl Acad Sci USA 77: 1588

    Article  PubMed  CAS  Google Scholar 

  • Rodt H et al. (1977) Classification of leukemic cells with T- and 0-ALL-specific antisera. In: Thierfelder S, Rodt H, Thiel E (eds) Hematology and blood transfusion, vol 20. Springer, Berlin Heidelberg New York, p 87

    Google Scholar 

  • Rodt H et al. (1975) Identification and quantitation of human T-cell antigen by antisera purified from antibodies crossreacting with hemopoietic progenitors and other blood cells. J Immunogenet 2: 411

    Article  Google Scholar 

  • Schlossman SF et al. (1976) Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci USA 73: 1288

    Article  PubMed  CAS  Google Scholar 

  • Sen L et al. (1975) Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N Engl J Med 292: 828

    Article  PubMed  CAS  Google Scholar 

  • Thiel E et al. (1980) Multimarker classification of acute lymphoblastic leukemia: Evidence for further T subgroups and evaluation of their clinical significance. Blood 56: 759

    PubMed  CAS  Google Scholar 

  • Thiel E et al. (1982) Comparison of currently available monoclonal antibodies with conventional markers for phenotyping one hundred acute leukemias. Blut 44: 95

    Article  PubMed  CAS  Google Scholar 

  • Thiel E et al. (1978) T-cell antigen positive, E-rosette

    Google Scholar 

  • negative acute lymphoblastic leukemia. Blut 36:363

    Google Scholar 

  • Thiel E et al. (1975) Quantitative immunoautoradiography at the cellular level. I. Design of a microphotometric method to quantitate membrane antigens on single cells using 125I-labeled antibodies. J Immunol Methods 6: 317

    Google Scholar 

  • Thiel E et al. (1976) Quantitative immunoautoradiography at the cellular level. II. Absolute measurements using labeled standard cells as a source of reference. J Immunol Methods 12: 237

    Article  PubMed  CAS  Google Scholar 

  • Thiel E et al. (1975) Decrease and altered distribution of human T antigen on chronic lymphatic leukemia cells of T type, suggesting a clonal origin. Blood 47: 723

    Google Scholar 

  • Vogler LB et al. (1978) A new phenotype of childhood lymphoblastic leukemia. N Engl J Med 298: 872

    Article  PubMed  CAS  Google Scholar 

  • Ziegler et al. (1981) TO 1: A monoclonal antibody defining a B-cell subpopulation. Leukemia Marker Conference, Wien (in press)

    Google Scholar 

  • Gielen W, Ber W, Arns W, Schaper R (1981) Serum-Sialyltransferase — ein Tumormarker? In: Uhlenbruck G, Wintzer G (Hrsg) CEA — Carcinoembryonales Antigen und andere Tumormarker. Tumor-Diagnostik-Verlag, Leonberg, S 332–341

    Google Scholar 

  • Herrmann WP, Gielen W (1979) Sialyltrans¬ferase levels and sialic acid concentrations in sera of patients with malignant melanomas. Arch Dermatol 265: 321–329

    Article  CAS  Google Scholar 

  • Kessel DH, Chou TH, Coomes RC (1981) Studies on sialyltransferase isoenzymes in plasma of patients with breast cancer. Eur J Cancer Clin Oncol 17: 1035–1040

    Google Scholar 

  • Mach JP, Buchegger F, Forni M, Ritschard J, Berche Ch, Lumbroso JD, Schreyer M, Girardet Ch, Accolla RS, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunology Today 2: 239–249

    Article  Google Scholar 

  • Paone JF, Baker RR, Waalkes TP, Shaper JH (1981) Sequential galactosyltransferase and carcinoembryonic antigen levels in advanced breast carcinoma. J Surg Res 31: 269–273

    Article  PubMed  CAS  Google Scholar 

  • Baldwin RW, Pimm MV (1977) Immunological adjuvants in experimental tumor immunotherapy. In: Miescher PA (ed) Proc. VIIth Internat. Symposium Immunopathology. Schwabe Publ., Basel, pp 397–410

    Google Scholar 

  • Bekesi JG, Holland JF, Roboz JP (1977) Specific immunotherapy with neuraminidase modified leukemic cells. Med Clin North Am 61: 1088

    Google Scholar 

  • Breard et al. (1982) Clin Exp Immunol 47: 735

    Google Scholar 

  • Chedid L, Audibert F (1977) Activity in saline of chemically well defined non-toxic bacterial adjuvants. In: Miescher PA (ed) Proc. VIIth Internat. Symposium Immunopathology. Schwabe Publ., Basel, p 382

    Google Scholar 

  • Chedid L, Miescher PA (1979) Symposium on immunostimulation. Conclusions. Semin Immunopathol 2: 229

    Google Scholar 

  • Cohen MH et al. (1979) Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. JAMA 241: 1813

    Article  PubMed  CAS  Google Scholar 

  • Goldstein AI, Low TLK, Thurman GB, Zatz MM, Mac Cure JE, Hall NR, Shu-Kuang H. Recent developments in the chemistry, biology and clinical applications of thymosin. Cellular responses to molecular modulators, p 237

    Google Scholar 

  • Gutschank S, Rothauge CF, Kraushaar J, Gutschank W, Sedlacek HH (1981) Das entgleiste metastasierende Prostatakarzinom. Effektivität der Kombination einer gegengeschlechtlich hormonalen und einer spezifisch immunstimulierenden Behandlung. München Med Wochenschr 123: 133

    Google Scholar 

  • Hadden JW, Giner-Sorolla A (1981) Isoprinosine and NPT 15392. Modulators of lymphocyte and macrophage development and function. In:Hersh EM et al (eds) Augmenting agents in cancer therapy. Raven Press, New York, p 497

    Google Scholar 

  • Immunstimulation (1979). Semin Immunopathol, Vol. 2, Springer, Berlin Heidelberg New York Hadden JW, Englard A, Sadlik JR, Hadden EM (1979) The comparative effects of isoprinosine, levamisole, MDP and SM 1213 on lymphocyte and macrophage proliferation and activation. Int J Immunopharmacol 1: 17

    Article  Google Scholar 

  • Lacour J, Lacour F, Spira A, Delage G, Michelson AM (1974) An immunotherapeutic trial of the adjuvant poly A: U in the management of breast cancer. Bull Cancer (Paris) 61: 275

    Google Scholar 

  • Low TLK, Goldstein AL (1979) Thymosin and other thymic hormones and their synthetic analogues. Semin Immunopathol 2: 169

    Article  CAS  Google Scholar 

  • Penn I (1981) Depressed immunity and the development of cancer. Clin Exp Immunol 46: 459

    PubMed  CAS  Google Scholar 

  • Renoux G, Renoux M (1977) Mécanismes d’action du lévamisole, stimulant les réponses d’immunité cellulaire. Ann Immunol (Paris) 128: C, 275

    Google Scholar 

  • Sedlacek HH, Weise M, Lemmer A, Seiler FR (1979) Immunotherapy of spontaneous mammary tumors in mongrel dogs with autologous tumor cells and neuraminidase. Cancer Immunol Immunother 6: 47

    Article  Google Scholar 

  • Sedlacek HH, Bengelsdorff HJ, Lemmert A, Seiler FR (1979) Approaches to effective tumor immunotherapy with cells and the enzyme neuraminidase. In: Muller-Ruchholtz W, Muller-Hermelink HK (eds) Function and structure of the immune system. Plenum Publ. Corp., p 789

    Chapter  Google Scholar 

  • Sikora K (1980) Does Interferon cure cancer. Br Med J 281: 855

    Article  PubMed  CAS  Google Scholar 

  • Stiehm ER (1982) Conference on the immunobiology and clinical significance of interferon. Ann Intern Med 96: 80

    Article  PubMed  CAS  Google Scholar 

  • Symoens J, Rosenthal M, Brabander M de, Goldstein G (1979) Immunoregulation with levamisole. Semin Immunopathol 2: 49

    CAS  Google Scholar 

  • Terman DS et al. (1981) Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 305: 1195

    Article  PubMed  CAS  Google Scholar 

  • Van Leyden VE, Blumenthal F (1902) Vorläufige Mitteilungen über einige Ergebnisse der Krebsforschung auf der 1. medizinischen Klinik. Dtsch Med Wochenschr 28: 637

    Article  Google Scholar 

  • Betzler M, Flad HD, Schlag P, Schreml W, Herfarth Ch (zur Publikation eingereicht) Natürliche Killerzell-Aktivität während einer Behandlung mit Fibroblasten-Interferon beim Magenkarzinom. Langenbecks Arch Chir Bundesminister für Forschung und Technologie (1981) Interferon, Eigenschaften, Gewinnung und Wirkung

    Google Scholar 

  • Heidemann E, Wilms K, Treuner J, Niethammer D (1982) Fibroblasten-Interferon zur Behandlung des Herpes zoster. Dtsch Med Wochenschr 18

    Google Scholar 

  • Mayer-Eichberger D und S, Treuner J, Joester K-E, Niethammer D (1981) Effects of IFN-alpha und IFN-beta on the proliferation of human cells in vitro. In: De Maeyer E et al. (eds) The biology of the interferon system. Elsevier/North Holland. Biomedical Press

    Google Scholar 

  • Müller R, Hochkeppel HK, Klein H

    Google Scholar 

  • a) Demonstration of HIFN-ß in the liver of patients undergoing HIFN-ß treatment. FEBS Lett 133 : 194–196

    Google Scholar 

  • Müller R, Siegert W, Hofschneider PH, Deinhardt F, Frösner G, Vido J, Schmidt FW (1981b) Treatment of chronic active Hepatitis B (CAHB) with human interferon-beta. In: De Maeyer E et al. (eds) The biology of the interferon system. Elsevier/North Holland Biomedical Press

    Google Scholar 

  • Müller R, Vido J, Schmidt FW (1979) Interferon: Therapie chronisch entzündlicher Erkrankungen. In: Forschungsergebnisse der Transfusionsmedizin und Immunhämatologie Bd 7. Medicus Verlag GmbH, Berlin

    Google Scholar 

  • Pape GR, Hadam MR, Eisenburg J, Riethmüller G (1981) Kinetics of natural cytotoxicity in patients treated with human fibroblast interferon. Cancer Immunol Immunother 11: 1–6

    Article  Google Scholar 

  • Schlag P, Wolfrum J, Schreml W, Herfarth Ch (zur Publikation eingereicht) Effect of fibroblast interferon on colony tumorgrowth of miscellaneous solid human tumors

    Google Scholar 

  • Siegert W, Theml H, Fink U, Emmerich B, Kandewitz P, Huhn D, Böning L, Abb I, Joester K-E, Riethmüller G, Wilmanns W (zur Publikation eingereicht) Treatment of non-hodgkin lymphoma of low grade malignancy with human fibroblast interferon —

    Google Scholar 

  • Sundmacher R, Neumann-Haefehn D, Cantell K (1976) Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht von Graefes Arch Klin Ophthalmol 201: 39–45

    Google Scholar 

  • Sundmacher R, Cantell K, Skoda R, Hallermann Ch, Neumann-Haefelin J (1978) Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht von Graefes Arch Klin Ophthalmol 208: 229–233

    CAS  Google Scholar 

  • Sundmacher R, Cantell K, Neumann-Haefelin D (1981) Evaluation of interferon in ocular viral diseases. In: De Maeyer E et al. (eds) The biology of the interferon system. Elsevier/North Holland Biomedical Press

    Google Scholar 

  • Treuner J, Dannecker G, Joester K-E, Hettinger A, Niethammer D (1981) Pharmacological aspects of clinical stage I/II trials with human beta-interferon in children. J Interferon Res 1: 373–380

    Article  PubMed  CAS  Google Scholar 

  • Treuner J, Dannecker G, Buck J, Dilger M, Diddens H, Niethammer D (zur Publikation eingereicht) The combined effect of interferon-ß and cytostatic drugs on human tumor cell lines in vitro

    Google Scholar 

  • Treuner J, Niethammer D, Dannecker G, Aldenhoff P, Kremens B, Nessler G, Bömer H (1981) Treatment of nasopharyngeal carcinoma in children with fibroblast interferon. In: Grundman et al. (eds) Fischer, Stuttgart New York

    Google Scholar 

  • Treuner J, Niethammer D, Dannecker G, Hagmann R, Neef V, Hofschneider PH (1980) Successful treatment of nasopharyngeal carcinoma with interferon. Lancet 1: 817–818

    Article  PubMed  CAS  Google Scholar 

  • Vallbracht A, Treuner J, Flehmig B, Joester K-E, Niethammer D (1981) Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature 289: 496–497

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Med. Univ.-Klinik Köln, Deutschland

    R. Gross

  2. Inst. für Immunbiologie, Univ. Freiburg, Deutschland

    S. Kleist

  3. Abt. Immunologie, Inst. für Hämatologie, GSF, München, Deutschland

    S. Thierfelder, E. Thiel, H. Rodt & U. Kummer

  4. Chirurg. Univ.-Klinik, Deutschland

    G. Wintzer

  5. Med. Univ.-Klinik Köln-Lindenthal, Deutschland

    G. Uhlenbruck

  6. Pharmakolog. Inst., Univ. Köln, Deutschland

    W. Gielen, W. Ber, W. Arns & R. Schaper

  7. Hämatolog. Abt., Kantonsspital Genf, Deutschland

    P. A. Miescher

  8. Max-Planck-Inst. für Biochemie Martinsried, Deutschland

    P. H. Hofschneider

  9. Bioferon, Laupheim, Deutschland

    H.-J. Obert

  10. Sloan-Kettering-Inst. for Cancer Research, Memorial Hospital, New York, USA

    H. F. Oettgen

Authors
  1. R. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kleist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Thierfelder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Thiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Rodt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Kummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Wintzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Uhlenbruck
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Gielen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. W. Ber
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. W. Arns
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R. Schaper
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. P. A. Miescher
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. P. H. Hofschneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. H.-J. Obert
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. H. F. Oettgen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kliniken der Landeshauptstadt Wiesbaden, D-6200, Wiesbaden, Deutschland

    Bernhard Schlegel

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gross, R. et al. (1982). Immunologische Aspekte in Diagnose und Therapie von Neoplasien. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 88. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47093-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-47093-6_11

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0332-0

  • Online ISBN: 978-3-642-47093-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation